venlafaxine hydrochloride has been researched along with Idiopathic Parkinson Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auinger, P; Christine, CW; Factor, SA; Juncos, J; Leentjens, AF; Lyness, JM; Marsh, L; McDonald, W; Moonen, AJ; Panisset, M; Pfeiffer, R; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J; Wijers, A | 1 |
Broen, MP; Köhler, S; Kuijf, ML; Leentjens, AF; McDonald, WM; Richard, IH | 1 |
Abeynaike, L; Rajapakse, S; Wickramarathne, T | 1 |
Friedman, JH; Weintraub, D | 1 |
Black, KJ; Brodsky, M; Christine, CW; Como, PG; Elmer, L; Factor, SA; Fernandez, HH; Horn, S; Hyson, HC; Jiang, W; Juncos, J; Kurlan, R; Lyness, JM; Manning, C; Marsh, L; McDermott, MP; McDonald, W; Panisset, M; Pearson, N; Pfeiffer, R; Press, D; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J | 1 |
Cunningham, LA | 1 |
Akyol, A; Bolukbasi, O | 1 |
1 review(s) available for venlafaxine hydrochloride and Idiopathic Parkinson Disease
Article | Year |
---|---|
Depression in the medically ill: choosing an antidepressant.
Topics: Antidepressive Agents; Cerebrovascular Disorders; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Decision Making; Dementia; Depressive Disorder; Humans; Neoplasms; Parkinson Disease; Prevalence; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1994 |
2 trial(s) available for venlafaxine hydrochloride and Idiopathic Parkinson Disease
Article | Year |
---|---|
Trajectories of recovery in depressed Parkinson's disease patients treated with paroxetine or venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Venlafaxine Hydrochloride | 2016 |
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Parkinson Disease; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2012 |
4 other study(ies) available for venlafaxine hydrochloride and Idiopathic Parkinson Disease
Article | Year |
---|---|
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
Topics: Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Datasets as Topic; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Venlafaxine Hydrochloride | 2014 |
Venlafaxine-associated serotonin syndrome causing severe rhabdomyolysis and acute renal failure in a patient with idiopathic Parkinson disease.
Topics: Acute Kidney Injury; Adult; Cyclohexanols; Humans; Male; Parkinson Disease; Rhabdomyolysis; Serotonin Syndrome; Venlafaxine Hydrochloride | 2010 |
Glad about SAD (PD).
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Parkinson Disease; Paroxetine; Venlafaxine Hydrochloride | 2012 |
Spontaneous erections and libido increase associated with venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Libido; Male; Middle Aged; Parkinson Disease; Penile Erection; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1999 |